Skip to main content
S 2897 118th Congress Senate Health Cancer Child health Congressional oversight Drug safety, medical device, and laboratory regulation Drug therapy Government studies and investigations Medical research Prescription drugs

Give Kids a Chance Act of 2023

Introduced: September 21, 2023 Introduced by: Bennet, Michael F. Democratic · Colorado See on congress.gov
Sign in to write a letter Sign in to watch
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Sep 21, 2023
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Sep 21, 2023
Introduced in Senate
 Plain-English summary Congressional Research Service

Give Kids a Chance Act of 2023

This bill authorizes certain targeted clinical trials involving combinations of drugs to treat pediatric cancer.

Specifically, the bill modifies requirements relating to molecularly targeted pediatric cancer investigations so as to authorize investigations of new drugs that are used in combination with active ingredients that have already been approved and that (1) have been determined to be the standard of care for treating a pediatric cancer, or (2) have been approved to treat an adult cancer and are directed at molecular targets for pediatric cancer.

The Food and Drug Administration must issue guidance and report on the bill's implementation. The Government Accountability Office must report on the effectiveness of the bill's changes with respect to the development of pediatric cancer drugs.

What's happening now September 21, 2023

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

 Committees of jurisdiction 1
 Cosponsors 4
All 4 Democratic 4